12:00 AM
Sep 21, 1998
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Resiniferatoxin: Phase II

Afferon said that preliminary results from a European Phase I/II trial showed improvement in 10 of 14 patients in such symptoms...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >